Salary:
Research Assistant £32,546 to £34,132 per annum
Research Associate: £35,116 to £45,413 per annum
Newcastle University is a great place to work, with excellent benefits. We have a generous holiday package; plus the opportunity to buy more, great pension schemes and a number of health and wellbeing initiatives to support you.
Closing Date: 27 May 2025
The Role
This new position provides an exciting opportunity to develop a project in applied, multimodal artificial intelligence. The role is offered as part of the Medical Research Council (MRC) ‘Impact accelerator award’, a scheme that focuses on developing novel biomarkers to practically improve patient care patient care and treatment. The project will leverage a unique dataset from patients with Mantle cell lymphoma, a rare and difficult to treat cancer.
The candidate will use high-resolution, gigapixel images from biopsies of patients diagnosed with Mantle cell lymphoma (MCL). We will scan and analyse almost 500 patient biopsy slides, and integrate these data with clinical information, other indicators of disease behaviour, and information about how patients responded to treatment. The ambition is to develop a standardised and effective model that can predict how lymphoma will behave in future patients, and to aid the effective choice of treatment.
Mantle Cell Lymphoma (MCL) is a rare lymphoma subtype, characterised by an often-aggressive nature and the lack of curative treatment, despite the impressive advances in new drugs like ‘BTK’ inhibitors and cellular immunotherapies. However, there exists a subgroup of MCL that progresses slowly, where immediate chemotherapy is unlikely to prolong a patient's life. There is currently no robust biomarker to thus differentiate ‘aggressive’ from ‘indolent’ MCL, which exposes some patients to unnecessary treatment and stretches medical resources.
Technological advancements in artificial intelligence (AI)-based computational pathology allow networks to extract defining histomorphological features from tumour sections and represent them digitally in AI architectures; when fused with clinical data and molecular determinants of tumour biology, these methods are anticipated to result in more generalisable and reproducible predictors of disease behaviour. We will develop a clinical risk model that accurately differentiates MCL phenotypes at diagnosis, personalising treatment and optimising resource management.
The candidate will be well supported within a multidisciplinary environment, comprising computer scientists and healthcare professionals. This is a collaboration between Newcastle University and the national MCL biobank (Liverpool). The co-supervisors in the school of computing have the required expertise and equipment to work with large volumes of anonymised data, and this work will complement that of a current Newcastle University PhD student (2024-), who is developing a broad classifier of lymph node pathology. Upon development of the MCL model, we will collaborate with an industrial partner to commercialise and deploy the model across health systems. There will be the opportunity to continue this work, contingent upon additional funding, including in the academic and commercial environment.
The multimodal data for this project comprise digitised images, textual pathology reports, patient metadata, and metrics of clinical outcome. Haematoxylin and eosin (H&E) diagnostic tissue sections from the MCL biobank (>500) will be scanned into high-resolution gigapixel images (40x magnification) at Novopath using whole slide imaging platforms (3DHistech P1500 & Roche). Pathology reports from diagnostic biopsies, along with fully anonymised metadata will pair image and text-metadata for each unique patient.
A multimodal deep learning framework will be developed by the RA under the supervision of Dr Xin (School of Computing). Programming will be in Python, with TensorFlow / Pytorch framework. Each data type will be processed using specialised pre-trained models from the public research community, such as ResNet or Vision Transformer (ViT) for images, BioBERT or ClinicalBERT for text, XGBoost or CatBoost for metadata. Feature representation from each data type will be aligned using methods like Contrastive Language–Image Pretraining (CLIP) to integrate features in a shared latent space. Cross-validation and weakly-supervised learning will help mitigate overfitting, while confidence scores (the model output) and intermediate visualisation will enhance model explainability and clinical usability.
The post is available on a full time, fixed term basis for 12 months.
For informal enquiries regarding the role, please contact Chris Carey (christopher.carey@newcastle.ac.uk).
Find out more about the Faculty of Medical Sciences here: https://www.ncl.ac.uk/medical-sciences/
Find out more about our Research Institutes here: https://www.ncl.ac.uk/medical-sciences/research/institutes/
As part of our commitment to career development for research colleagues, the University has developed 3 levels of research role profiles. These profiles set out firstly the generic competences and responsibilities expected of role holders at each level and secondly the general qualifications and experiences needed for entry at a particular level.
Goals of the Study
Key Accountabilities
The Person
Knowledge, Skills and Experience
Attributes and Behaviour
Qualifications
Newcastle University is a global University where everyone is treated with dignity and respect. As a University of Sanctuary, we aim to provide a welcoming place of safety for all, offering opportunities to people fleeing violence and persecution.
We are committed to being a fully inclusive university which actively recruits, supports and retains colleagues from all sectors of society. We value diversity as well as celebrate, support and thrive on the contributions of all of our employees and the communities they represent. We are proud to be an equal opportunities employer and encourage applications from individuals who can complement our existing teams, we believe that success is built on having teams whose backgrounds and experiences reflect the diversity of our university and student population.
At Newcastle University we hold a silver Athena Swan award in recognition of our good employment practices for the advancement of gender equality. We also hold a Race Equality Charter Bronze award in recognition of our work towards tackling race inequality in higher education REC. We are a Disability Confident employer and will offer an interview to disabled applicants who meet the essential criteria for the role as part of the offer and interview scheme.
In addition, we are a member of the Euraxess initiative supporting researchers in Europe.
Requisition ID: 28139